immun
respons
mani
commonli
encount
viral
infect
result
viral
clearanc
therefor
continu
replic
viral
infect
repres
scenario
ineffect
immun
respons
immun
toler
mechanist
studi
persist
replic
viral
infect
includ
lymphocyt
choriomeneng
viru
lcmv
murin
hepat
viru
mhv
mous
model
provid
numer
insight
immun
mechan
viral
persist
gener
studi
model
focus
adapt
immun
toler
loss
adapt
immun
function
determin
viral
persist
thu
paradigm
emerg
viral
persist
link
defect
toler
adapt
immun
respons
norovirus
nov
lead
caus
epidem
viral
gastroenter
worldwid
human
nov
close
relat
murin
nov
mnov
also
establish
persist
asymptomat
infect
may
contribut
spread
populationlevel
persist
outbreak
studi
mnov
strain
differ
persist
begun
identifi
viral
host
correl
persist
infect
mnov
strain
clear
wherea
strain
persist
wild
type
mice
recent
discov
persist
intestin
infect
clear
innat
respons
requir
adapt
immun
respons
close
relat
type
ifn
special
role
epitheli
surfac
find
suggest
adapt
immun
respons
alway
necessari
control
persist
infect
ifn
respons
play
role
mnov
persist
wherea
clear
intestin
persist
type
ifn
respons
prevent
system
spread
persist
infect
spread
system
control
earli
type
ifn
respons
therefor
present
studi
sought
identifi
role
type
ifn
control
system
persist
found
type
ifn
receptor
ifnar
express
dendrit
cell
dc
necessari
clearanc
adapt
immun
respons
gener
mice
ifnar
defici
dc
increas
magnitud
commensur
increas
earli
viral
replic
function
capac
adapt
immun
cell
maintain
persist
infect
therefor
persist
model
repres
exampl
viral
persist
due
innat
rather
adapt
immun
defici
cytosol
rna
receptor
membran
tolllik
receptor
cooper
sens
viral
infect
lead
induct
type
type
iii
ifn
examin
abil
persist
mesenter
lymph
node
mln
mice
lack
cytosol
rna
sensor
downstream
signal
transduc
molecul
mav
mav
also
examin
mice
lack
signal
transduc
toll
like
receptor
tlr
signal
trif
none
individu
signal
molecul
critic
clearanc
fig
howev
mice
lack
transcript
factor
util
interferon
gene
transcript
cytosol
sens
tlr
pathway
fail
clear
fig
thu
global
defect
induct
ifn
lead
viral
persist
mice
succumb
infect
within
seven
day
indic
type
ifn
respons
critic
control
fig
recent
shown
mice
select
delet
macrophag
floxflox
x
lysmcr
dc
floxflox
x
also
exhibit
increas
titer
earli
inocul
howev
unlik
mice
lineagespecif
defici
mice
surviv
infect
assess
viral
clearanc
mice
sacrif
mice
day
inocul
measur
viral
genom
mln
persist
detect
mice
either
lysmspecif
defici
fig
contrast
creneg
litterm
control
mice
mice
lack
ifnar
villinexpress
intestin
epitheli
cell
floxflox
x
villincr
abl
clear
infect
fig
togeth
data
indic
reduc
induct
ifn
failur
myeloid
cell
subset
respond
type
ifn
result
persist
immunocompet
mice
persist
mnov
strain
specif
local
intestin
mln
wherea
spread
system
persist
therefor
assess
tropism
time
mice
delet
subsequ
refer
viral
genom
copi
dramat
increas
mice
four
day
inocul
system
intestin
tissu
well
stool
fig
greatest
differ
genom
copi
number
day
four
spleen
liver
mln
clear
tissu
control
mice
day
inocul
high
titer
mice
partli
control
day
day
reduct
viral
genom
fold
fig
howev
persist
viral
genom
observ
spleen
liver
mln
mice
least
day
fig
sporad
detect
ileum
colon
mice
day
undetect
stool
mice
day
fig
thu
persist
primarili
local
system
rather
intestin
tissu
similarli
persist
spleen
mln
colon
mice
fig
data
consist
primari
role
type
ifn
respons
dc
broadli
limit
earli
viral
replic
prevent
viral
persist
system
tissu
earli
increas
viral
genom
system
tissu
suggest
interferonstimul
gene
isg
gene
relat
ifn
signal
recruit
immun
cell
may
appropri
regul
mice
therefor
quantifi
repres
isg
chemokin
spleen
day
inocul
determin
broad
defect
induct
antivir
transcript
respons
cellintrins
antivir
mediat
present
significantli
greater
quantiti
mice
fig
addit
transcript
cell
chemokin
increas
transcript
macrophag
chemokin
unchang
mice
fig
data
demonstr
ifnstimul
gene
chemokin
similar
increas
mice
persist
mice
indic
absenc
adapt
immun
respons
permit
persist
dc
activ
antigen
present
central
initi
adapt
immun
respons
replic
myeloid
cell
includ
dc
therefor
test
whether
increas
viral
replic
mice
correl
chang
dc
number
activ
three
day
inocul
number
dc
mice
unchang
rel
mice
creneg
litterm
control
fig
furthermor
dc
mice
exhibit
increas
cell
surfac
express
mhci
kb
mhcii
costimulatori
molecul
compar
litterm
control
fig
data
demonstr
type
ifn
signal
dc
necessari
matur
context
fact
observ
increas
activ
dc
mice
correl
increas
viral
replic
fig
nk
cell
express
low
level
therefor
may
alter
express
mice
inde
stain
nk
cell
spleen
three
day
inocul
express
similar
express
modestli
reduc
mice
assess
nk
cell
number
express
surfac
marker
determin
nk
cell
recruit
differenti
alter
reduc
express
nk
cell
number
unchang
fig
nk
cell
express
chang
express
modestli
increas
mice
fig
data
suggest
modest
reduct
express
nk
cell
alter
recruit
substanti
chang
activ
follow
infect
antibodi
respons
import
keep
persist
viral
infect
check
make
loss
humor
immun
mice
potenti
basi
viral
persist
assess
humor
immun
respons
mice
measur
antibodi
respons
viral
particl
protein
elisa
titer
serum
antibodi
viral
particl
viral
protein
significantli
higher
respect
mice
compar
litterm
control
fig
determin
increas
antibodi
titer
result
enhanc
neutral
viral
particl
perform
serum
neutral
assay
serum
mice
effect
neutral
pfu
serum
litterm
control
dilut
fig
togeth
data
demonstr
increas
seroconvers
viru
neutral
mice
thu
persist
mice
correl
defect
humor
immun
instead
humor
immun
respons
persist
infect
mice
enhanc
similar
nk
cell
cell
express
low
level
activ
therefor
stain
cell
express
determin
alter
mice
cell
mice
less
uninfect
mice
less
express
day
postinocul
fig
thu
express
modestli
reduc
cell
mice
may
impact
activ
respons
virallyinduc
ifn
prior
work
identifi
immunodomin
cell
epitop
use
assess
cellular
immun
respons
mice
peak
cell
expans
eight
day
inocul
observ
increas
proport
cell
spleen
mln
peyer
patch
mice
compar
creneg
litterm
control
fig
likewis
greater
proport
cell
spleen
mice
respond
express
degranul
marker
follow
peptid
restimul
ex
vivo
fig
among
cell
respond
peptid
restimul
vitro
signific
differ
number
simultan
function
product
product
degranul
per
cell
fig
determin
increas
cell
cytokin
respons
vivo
quantifi
transcript
granzym
b
spleen
mice
day
inocul
increas
transcript
granzym
b
transcript
unchang
fig
togeth
data
indic
although
decreas
cell
express
persist
mice
correl
defect
cell
expans
function
fact
increas
expans
equal
function
cell
mice
earli
cell
expans
persist
infect
follow
clonal
loss
clonal
dysfunct
therefor
assess
cell
respons
day
inocul
determin
whether
loss
cell
decreas
cell
function
day
increas
proport
cell
spleen
mice
compar
control
mice
fig
also
increas
proport
cell
spleen
mice
express
follow
peptid
restimul
ex
vivo
fig
furthermor
differ
number
simultan
function
per
cell
follow
peptid
restimul
fig
also
analyz
cell
surfac
express
follow
protein
upregul
transient
activ
sustain
exhaust
cell
upregul
sustain
activ
downregul
exhaust
cell
transient
downregul
activ
differ
express
cell
surfac
protein
cell
mice
comparison
creneg
litterm
control
fig
final
quantifi
vivo
transcript
granzym
b
observ
increas
transcript
granzym
b
signific
differ
transcript
fig
togeth
data
indic
virusspecif
cell
mice
maintain
higher
frequenc
remain
function
persist
infect
enhanc
adapt
immun
respons
mice
fig
correl
increas
earli
viral
replic
reduc
viral
titer
time
result
elimin
viru
system
tissu
fig
although
dc
activ
fig
cell
respons
initi
fig
consid
possibl
virallyinfect
dc
unabl
present
viral
antigen
activ
cell
test
possibl
util
strain
engin
express
peptid
siinfekl
chicken
ovalbumin
antibodi
recogn
siinfekl
groov
class
mhc
molecul
dc
macrophag
b
cell
infect
wherea
cell
shown
support
infect
stain
splenocyt
three
day
inocul
show
modest
increas
stain
intens
siinfeklkb
b
cell
macrophag
dc
cell
follow
inocul
compar
correspond
cell
mice
inocul
fig
therefor
absenc
prevent
display
antigen
cell
suscept
viral
infect
howev
remain
possibl
develop
mutat
evad
recognit
cell
determin
mutat
cell
epitop
occur
persist
infect
sequenc
viru
spleen
perform
day
inocul
examin
sequenc
persist
reveal
deviat
cell
epitop
sequenc
viru
inoculum
fig
therefor
cell
respons
fail
clear
despit
persist
unmut
epitop
sequenc
preced
data
suggest
despit
present
antigen
gener
cellular
immun
function
adapt
immun
respons
could
significantli
diminish
viral
infect
could
fulli
clear
innat
immun
cell
test
function
adapt
immun
system
set
viral
infect
cell
util
previous
publish
splenocyt
transfer
cell
cell
contribut
clearanc
viral
infect
litterm
control
mice
infect
day
later
splenocyt
isol
transfer
persist
infect
mice
six
day
splenocyt
transfer
genom
detect
qpcr
spleen
ileum
viral
titer
determin
mice
plaqu
assay
splenocyt
either
litterm
control
donor
similarli
abl
clear
pfu
spleen
ileum
fig
likewis
splenocyt
either
donor
similarli
abl
reduc
viral
genom
spleen
ileum
fig
data
demonstr
adapt
immun
respons
mice
includ
cell
function
environ
vivo
suggest
increas
viral
replic
cell
suffici
establish
persist
viral
replic
despit
function
adapt
immun
respons
data
thu
far
strongli
suggest
dc
stimul
adapt
immun
prevent
ifnar
defici
next
sought
determin
whether
presenc
subpopul
ifnardefici
cell
suffici
increas
replic
end
gener
mix
bone
marrow
chimera
reconstitut
irradi
congen
recipi
mixtur
bone
marrow
congen
wildtyp
bone
marrow
control
separ
cohort
irradi
recipi
reconstitut
mixtur
wildtyp
bone
marrow
congen
wildtyp
bone
marrow
six
week
reconstitut
equival
proport
express
cell
blood
group
indic
equal
engraft
cell
donor
fig
six
week
reconstitut
mix
bone
marrow
chimera
inocul
three
day
inocul
amount
viral
genom
blood
determin
measur
earli
system
viral
replic
bone
marrow
chimera
unabl
control
earli
system
viral
replic
viral
genom
per
microlit
blood
compar
control
chimera
fig
furthermor
earli
shed
viral
genom
fece
bone
marrow
chimera
day
five
seven
increas
respect
compar
control
chimera
fig
demonstr
presenc
subpopul
ifnardefici
dc
suffici
increas
earli
viral
replic
correspondingli
presenc
mix
wildtyp
leukocyt
suffici
enabl
earli
viral
control
unexpectedli
mix
bone
marrow
chimera
increas
suscept
infect
three
eight
chimera
die
prior
day
eight
addit
one
control
mous
die
day
fig
day
observ
reduc
number
lymphocyt
spleen
surviv
compar
control
chimera
fig
increas
lethal
reduc
number
leukocyt
suggest
process
bone
marrow
transplant
result
immunocompromis
state
increas
suscept
howev
number
chimer
dc
bone
marrow
chimera
significantli
differ
control
chimera
fig
allow
us
compar
viral
titer
surviv
mice
two
group
viral
genom
significantli
higher
spleen
liver
mln
colon
bone
marrow
chimera
compar
control
chimera
fig
data
indic
presenc
mix
wildtyp
dc
rescu
control
persist
viral
replic
taken
togeth
preced
data
suggest
presenc
subpopul
cell
increas
suscept
infect
suffici
increas
earli
persist
viral
replic
shown
select
defici
type
ifn
respons
dc
result
mnov
persist
prior
studi
util
lcmv
model
causal
link
diminish
cell
function
viral
persist
studi
demonstr
role
type
ifn
regul
process
furthermor
antigen
abund
posit
correl
degre
cell
dysfunct
mnov
persist
demonstr
herein
contrast
paradigm
associ
failur
gener
adapt
immun
respons
loss
adapt
immun
function
fact
enhanc
adapt
immun
respons
commensur
increas
viral
replic
enhanc
adapt
immun
respons
sustain
persist
infect
data
demonstr
innat
immun
defect
type
ifn
result
viral
persist
without
attend
effect
adapt
arm
immun
system
result
provid
differ
view
viral
persist
prior
work
lcmv
model
howev
import
note
antigen
abund
may
lower
mnov
model
rel
lcmv
model
addit
import
type
ifn
protect
lethal
infect
differ
lcmv
provid
potenti
basi
differ
role
type
ifn
two
model
mnov
model
persist
studi
observ
increas
viral
replic
due
defect
type
ifn
pathway
link
viral
persist
ifnar
mice
high
earli
viral
replic
succumb
infect
mice
margin
lower
peak
viral
replic
allow
persist
lineag
specif
delet
lysm
express
cell
also
result
less
viral
replic
ifnar
allow
mnov
persist
mice
small
increas
viral
replic
abl
clear
infect
lineag
specif
delet
villinexpress
cell
lead
chang
viral
titer
clearanc
rel
greater
effect
ifnar
myeloid
cell
rather
intestin
epitheli
cell
like
due
preferenti
replic
myeloid
cell
andor
low
ifnar
express
intestin
epitheli
cell
togeth
find
support
model
vari
level
type
ifn
signal
invers
correl
peak
viral
replic
viral
clearanc
addit
conclus
data
viral
titer
alway
posit
correl
adapt
immun
dysfunct
lcmv
model
increas
viral
titer
associ
antigen
level
predict
cell
clonal
delet
loss
cell
function
unlik
lcmv
model
persist
infect
mice
correl
loss
cell
number
function
instead
increas
viral
titer
balanc
commensur
increas
cell
expans
antibodi
product
wild
type
mice
intact
innat
control
rel
lower
level
cell
expans
antibodi
product
mice
repres
unbalanc
scenario
uncontrol
earli
viral
replic
result
death
prior
develop
adapt
respons
mice
repres
sweet
spot
increas
viral
growth
control
clear
enhanc
adapt
immun
respons
result
persist
balanc
viral
replic
clearanc
fig
model
simplist
consid
compon
innat
immun
respons
repres
rational
viral
persist
presenc
enhanc
adapt
immun
respons
implic
model
primari
mechanist
basi
certain
persist
infect
could
manipul
ifn
innat
antivir
respons
likewis
data
impli
persist
infect
could
treat
modul
innat
immun
particularli
type
ifn
rather
target
adapt
immun
respons
inde
principl
manifest
persist
hcv
infect
human
hcv
proteas
inhibit
induct
ifn
cleav
mav
prior
recent
develop
small
molecul
inhibitor
hcv
replic
effect
therapi
persist
hcv
infect
includ
ifn
treatment
success
treatment
hcv
serv
circumv
viral
inhibit
ifn
induct
thu
hcv
may
exampl
medic
relev
persist
viral
infect
persist
due
part
loss
innat
immun
function
persist
continu
replic
rna
virus
chikungunya
measl
polyomaviru
may
similarli
due
ineffect
innat
respons
floxflox
lysmcr
cre
ifo
tg
itgaxcr
egfp
villincr
tg
gum
mav
mice
maintain
washington
univers
describ
mice
bred
background
creneg
litterm
floxflox
x
villincr
floxflox
x
lysmcr
floxflox
x
cross
use
control
experi
indic
mice
use
control
mice
infect
week
age
mnov
strain
stock
gener
describ
dilut
media
concentr
pfu
per
ml
pfu
administ
oral
pipet
mous
gener
insert
epitop
encod
sequenc
polyprotein
previous
describ
congen
mice
use
bone
marrow
recipi
obtain
jackson
laboratori
bar
harbor
hous
oregon
health
scienc
univers
bone
marrow
isol
congen
mice
experiment
mice
mix
ratio
recipi
mice
irradi
total
donor
bone
marrow
cell
inject
intraven
mice
given
ciprofloxacin
drink
water
two
week
use
experi
six
week
protocol
anim
care
use
approv
anim
studi
committe
washington
univers
st
loui
protocol
oregon
health
scienc
univers
protocol
accord
standard
set
forth
anim
welfar
act
tissu
dissect
flash
frozen
rna
tissu
isol
use
trizol
life
technolog
dna
remov
use
dnafre
kit
life
technolog
rna
stool
isol
use
zr
viral
rna
kit
zymoresearch
rna
revers
transcrib
use
impromii
revers
transcriptas
system
promega
mnov
genom
quantiti
transcript
housekeep
gene
ribosom
protein
detect
use
follow
primer
probe
mnov
forward
primer
cacgccaccgatctgttctg
mnov
mgb
probe
cgctttggaacaatg
mnov
revers
primer
gcgctgcgccatcactc
forward
primer
gcaaatacgggctgaacatg
probe
ccttcgcgtactgccggaagc
revers
primer
gtccaacttaatgaagcctatgtc
transcript
ifng
tnfa
gzmb
detect
use
primetim
qpcr
assay
integr
dna
technolog
idt
copi
number
determin
use
standard
curv
gener
dilut
plasmid
encod
target
sequenc
interest
immulon
plate
thermo
fisher
coat
uv
inactiv
mnov
virion
bacteriallyproduc
mnov
amino
acid
pb
plate
wash
three
time
elisa
wash
buffer
nacl
tween
block
bovin
serum
albumin
serum
dilut
elisa
iii
buffer
nacl
edta
tri
tween
bsa
ph
ad
plate
hour
unbound
serum
antibodi
remov
wash
four
time
elisa
wash
buffer
goatantimousehrp
jackson
immunoresearch
dilut
elisa
iii
buffer
ad
plate
hour
plate
wash
four
time
elisa
wash
buffer
hrp
activ
detect
ad
elisa
substrat
buffer
sodium
citrat
abt
hydrogen
peroxid
stop
phosphor
acid
absorb
measur
serum
mice
infect
day
mnov
heat
inactiv
minut
dilut
cell
cultur
media
dmem
supplement
fetal
calf
serum
lglutamin
hepe
pennecilinstreptamycin
pfu
mnov
strain
ad
serum
dilut
total
volum
incub
room
temperatur
minut
prior
inocul
raw
cell
monolay
sixwel
plate
inocul
raw
cell
plaqu
assay
perform
describ
spleen
mesenter
lymph
node
peyer
patch
remov
forc
cell
strainer
creat
singl
cell
suspens
red
blood
cell
splenocyt
suspens
lyse
ammonium
chlorid
potassium
ack
lyse
buffer
sigma
dead
cell
stain
livedead
aqua
life
technolog
surfac
antigen
stain
follow
antibodi
ebiosci
clone
mhcii
biolegend
clone
biolegend
clone
bd
bioscienc
clone
bd
bioscienc
clone
biolegend
clone
mhcikb
bd
bioscienc
clone
bd
bioscienc
clone
biolegend
clone
biolegend
clone
biolegend
clone
biolegend
clone
biolegend
clone
tonbo
clone
biolegend
clone
siinfekl
peptid
grove
antibodi
biolegend
clone
biolegend
clone
biolegend
clone
mhci
kb
tetram
immunodomin
epitop
swvprlyql
gener
describ
splenocyt
incub
round
bottom
plate
triplic
monensin
biolegend
brefeldina
biolegend
peptid
swvprlyql
antibodi
ebiosci
clone
four
five
hour
cell
surfac
stain
follow
fixat
permeabil
use
cytofixcytoperm
kit
bd
bioscienc
permeabil
cell
stain
antibodi
biolegend
clone
bd
bioscienc
clone
analyz
flow
cytometri
adopt
transfer
splenocyt
persist
infect
mice
perform
describ
briefli
splenocyt
isol
donor
infect
red
blood
cell
lyse
splenocyt
inject
ip
recipi
infect
day
six
day
transfer
tissu
harvest
pfu
determin
plaqu
assay
genom
quantifi
qpcr
